Trial intelligence / Profile preview

GR-CWI: Intralesional Ropivacaine and Methylprednisolone for Post-Abdominal Surgery Pain

NCT02002663Phase 3Completed

Sponsor
IRCCS San Matteo Foundation
Start
Aug 2013
Primary completion
Jun 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ropivacaine, methylprednisolone in postoperative pain, sponsored by IRCCS San Matteo Foundation. Started Aug 2013; status: completed.

02

Drugs

ropivacainemethylprednisolone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02002663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02002663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call